tiprankstipranks
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
Holding WST?
Track your performance easily

West Pharmaceutical Services (WST) Financial Statements

645 Followers

West Pharmaceutical Services Financial Overview

West Pharmaceutical Services's market cap is currently ―. The company's EPS TTM is $7.577; its P/E ratio is 42.62; and it has a dividend yield of 0.24%. West Pharmaceutical Services is scheduled to report earnings on July 25, 2024, and the estimated EPS forecast is $1.74. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 732.00M$ 747.40M$ 753.80M$ 716.60M$ 708.70M
Gross Profit$ 278.20M$ 288.30M$ 291.40M$ 271.30M$ 262.10M
EBIT$ 169.40M$ 189.90M$ 187.60M$ 165.80M$ 130.70M
EBITDA$ 205.30M$ 225.60M$ 221.70M$ 197.40M-
Net Income Common Stockholders$ 137.00M$ 172.50M$ 155.10M$ 140.00M$ 103.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 853.90M$ 898.60M$ 796.30M$ 886.30M$ 894.30M
Total Assets$ 3.83B$ 3.75B$ 3.67B$ 3.72B$ 3.51B
Total Debt$ 309.00M$ 306.80M$ 311.30M$ 314.40M$ 317.90M
Net Debt$ -544.90M$ -591.80M$ -485.00M$ -571.90M$ -576.40M
Total Liabilities$ 948.50M$ 886.50M$ 922.90M$ 947.40M$ 3.62B
Stockholders Equity$ 2.88B$ 2.87B$ 2.75B$ 2.78B$ 2.68B
Cash Flow-
Free Cash Flow$ 130.40M$ 134.30M$ 93.80M$ 56.00M$ 135.90M
Operating Cash Flow$ 239.10M$ 230.10M$ 169.20M$ 138.10M$ 230.80M
Investing Cash Flow$ -108.80M$ -95.70M$ -82.10M$ -82.10M$ -94.80M
Financing Cash Flow$ -189.50M$ -22.30M$ -176.80M$ -71.00M$ -9.50M
Currency in USD

West Pharmaceutical Services Earnings and Revenue History

West Pharmaceutical Services Debt to Assets

West Pharmaceutical Services Cash Flow

West Pharmaceutical Services Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis